Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
12.65
-0.32 (-2.47%)
At close: Jun 12, 2026, 4:00 PM EDT
12.80
+0.15 (1.21%)
After-hours: Jun 12, 2026, 7:59 PM EDT

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
748509448272159305
Market Cap Growth
58.67%13.81%64.53%71.60%-48.00%499.98%
Enterprise Value
548.34381.61438.41248.0889.82194.14
Last Close Price
12.658.968.346.554.598.71
PE Ratio
6.376.64----
Forward PE
22.7219.15----
PS Ratio
6.124.7818.969.9115.1610.64
PB Ratio
3.633.2911.284.392.112.40
P/FCF Ratio
62.34----29.50
P/OCF Ratio
58.58----29.21
EV/Sales Ratio
4.483.5818.579.038.596.78
EV/EBITDA Ratio
43.06----24.31
EV/EBIT Ratio
55.05----25.12
EV/FCF Ratio
45.71----18.78
Debt / Equity Ratio
0.000.411.510.700.180.01
Debt / EBITDA Ratio
-----0.20
Debt / FCF Ratio
0.10----0.15
Net Debt / Equity Ratio
-0.97-0.83-0.23-0.39-0.92-0.87
Net Debt / EBITDA Ratio
38.012.170.110.491.65-13.87
Net Debt / FCF Ratio
-16.6352.530.130.713.65-10.71
Asset Turnover
0.430.460.130.190.080.40
Inventory Turnover
8.418.897.53---
Quick Ratio
4.745.462.351.157.5826.92
Current Ratio
4.895.682.531.187.7227.20
Return on Equity (ROE)
62.17%85.66%-207.75%-67.27%-41.11%-28.18%
Return on Assets (ROA)
-3.06%-28.28%-41.18%-34.49%-34.88%10.68%
Return on Invested Capital (ROIC)
-12.39%-74.20%-62.37%-62.37%-182.53%67.55%
Return on Capital Employed (ROCE)
-3.36%-32.32%-71.71%-49.13%-36.64%11.68%
Earnings Yield
15.65%15.07%----
FCF Yield
1.60%----3.39%
Buyback Yield / Dilution
-19.19%-23.81%-30.46%-2.79%-15.87%-647.71%
Total Shareholder Return
-19.19%-23.81%-30.46%-2.79%-15.87%-647.71%
SEC Filings: 10-K · 10-Q